Zeria Pharmaceutical Co (TSE:4559) Institutional Ownership: 11.62% (As of Aug. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4559 Zeria Pharmaceutical Co Ltd TSE:4559
83 GF Score
Price 円2,111.00
GF Value 円2,516.73
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Zeria Pharmaceutical Co Institutional Ownership?

Zeria Pharmaceutical Co TSE:4559 +1.49% 83 Institutional Ownership is 11.62% as of Aug. 15, 2026. GuruFocus rates TSE:4559 with a GF Score™ of 83/100 and a GF Value™ of 円2,516.73 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Zeria Pharmaceutical Co's institutional ownership is 11.62%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Zeria Pharmaceutical Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Zeria Pharmaceutical Co's Float Percentage Of Total Shares Outstanding is 0.00%.

Zeria Pharmaceutical Co Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Zeria Pharmaceutical Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zeria Pharmaceutical Co Institutional Ownership Chart

Zeria Pharmaceutical Co Historical Data

The historical data trend for Zeria Pharmaceutical Co can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 11.64 11.85 11.35 11.43 11.49 11.33 11.53 11.53 11.73 11.62
TSE:4559
83GF Score
Zeria Pharmaceutical Co Ltd TSE:4559
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zeria Pharmaceutical Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 11.62% mean?
Zeria Pharmaceutical Co (TSE:4559) has a Institutional Ownership of 11.62% as of Aug. 15, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Zeria Pharmaceutical Co and its competitors.
Is Zeria Pharmaceutical Co's Institutional Ownership too high?
Zeria Pharmaceutical Co's current Institutional Ownership is 11.62%. Overall, Zeria Pharmaceutical Co has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zeria Pharmaceutical Co's Institutional Ownership compare to ZTS?
Zeria Pharmaceutical Co's Institutional Ownership of 11.62% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Zeria Pharmaceutical Co and its competitors. Zeria Pharmaceutical Co's current Institutional Ownership is 11.62%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zeria Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zeria Pharmaceutical Co (TSE:4559) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,516.73, compared to a current price of 円2,111.00 — trading 16.1% below its estimated fair value. The current Institutional Ownership is 11.62%. Zeria Pharmaceutical Co's overall GF Score™ is 83/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Zeria Pharmaceutical Co (TSE:4559), the current Institutional Ownership is 11.62% as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zeria Pharmaceutical Co (TSE:4559) Overvalued in 2026?

Based on GuruFocus' analysis, Zeria Pharmaceutical Co stock appears to be undervalued. The current stock price of 円2,111.00 is trading 16.1% below its estimated GF Value™ of 円2,516.73. GuruFocus considers Zeria Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for TSE:4559:

  • Institutional Ownership: 11.62%
  • GF Value™: 円2,516.73 vs. price of 円2,111.00 (16.1% below fair value)
  • GF Score™: 83/100 with 2 warning signs

No single metric tells the full story. See the TSE:4559 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zeria Pharmaceutical Co Business Description

Address 10-11, Nihonbashi Kobuna-cho, Tokyo, JPN, 103-8351
Zeria Pharmaceutical Co Ltd is a Japanese pharmaceutical company. The company through its subsidiaries engages in two business divisions which include ethical pharmaceutical products and consumer healthcare products business division. It principally manufactures, sells, imports and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, reagents, cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, and health equipment.
83GF Score

Get the complete analysis for TSE:4559

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,111.00
Price
円2,516.73
GF Value